Evaluation of fluorine-18-fluorodeoxyglucose whole body positron emission tomography imaging in the staging of lung cancer

Annals of Thoracic Surgery

Volumn 67, Issue 3, 1999, Pages 790-797

  Saunders, Catherine A B ^a,c   Dussek, Julian E ^b   O'Doherty, Michael J ^a   Maisey, Michael N ^a  

^a GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

^b ST THOMAS HOSPITAL   (United Kingdom)

^c BANKSTOWN LIDCOMBE HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORINE 18; FLUORODEOXYGLUCOSE;

ADULT; AGED; ARTICLE; CANCER CELL; CANCER STAGING; COMPUTER ASSISTED TOMOGRAPHY; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC ACCURACY; FEMALE; FOLLOW UP; GLUCOSE INTAKE; HUMAN; IMAGE ANALYSIS; IMAGING SYSTEM; LUNG BIOPSY; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROGNOSIS;

EID: 0032892604     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0003-4975(98)01257-0     Document Type: Article

References (23)

1. Office of National Statistics. Lung cancer incidence from 1979-1993. United Kingdom.
2. Kerr K.M., Lamb D., Wathem C.G., Walker W.S., Douglas N.J. Pathological assessment of mediastinal lymph node in lung cancer implications for non-invasive mediastinal staging . Thorax. 47:1992;337-341.
3. Libshitz H.I., McKenna R.J. Mediastinal lymph node size in lung cancer. Am J Roentgenol. 143:1984;715-718.
4. Muers M. Preoperative screening for metastases in lung cancer. Thorax. 49:1994;1-2.
5. Investigation for mediastinal disease in patients with apparently operable lung cancer. Ann Thorac Surg. 60:1995;1382-1389.
6. Dillemans B., Deneffe G., Verschakelen J., Decramer M. Value of computed tomography and mediastinoscopy in preoperative evaluation of mediastinal nodes in non-small cell lung cancer. Eur J Cardio-thorac Surg. 8:1994;37-42.
7. Luke M.P., Pearson F., Todd T.R.J., Patterson G.A., Cooper J. Prospective evaluation of mediastinoscopy for assessment of carcinoma of the lung. J Thorac Cardiovasc Surg. 91:1986;53-56.
8. Bury T., Dowlati A., Paulus P., et al. Evaluation of the solitary pulmonary nodule by positron emission tomography imaging. Eur Respir J. 9:1996;410-414.
9. Bury T., Dowlati A., Paulus P., Hustinx R., Radermecker M., Rigo P. Staging of non-small-cell lung cancer by whole body fluorine-18 deoxyglucose positron emission tomography. Eur J Nucl Med. 23:1996;204-206.
10. Sasaki M., Ichiya Y., Kuwabara Y., et al. The usefulness of FDG positron emission tomography for the detection of mediastinal lymph node metastases in patients with non-small cell lung cancer a comparative study with X-ray computed tomography . Eur J Nucl Med. 23:1996;741-747.
11. Steinhert H.C., Hauser M., Allemann F., et al. Non small cell lung cancer nodal staging with FDG PET versus CT with correlative lymph node mapping and sampling . Radiology. 202:1997;441-446.
12. Sazon D.A., Santiago S.M., Soo Hoo G.W., et al. Fluorodeoxyglucose positron emission tomography in the detection and staging of lung cancer. Am J Resp Crit Care Med. 153:1996;417-421.
13. 18F-fluorodeoxyglucose positron emission tomography in preoperative evaluation of lung cancer. Lancet. 344:1994;1265-1266.
14. Gambhir S.S., Hoh C.K., Phelps M.E., Madar I., Maddahi J. Decision tree sensitivity analysis for cost- effectiveness of FDG-PET in the staging and management of non-small-cell lung carcinoma. J Nucl Med. 37:1996;1428-1436.
15. Mountain CF. A new international staging system for lung cancer (review). Chest 1986;89:225-33S.
16. Zasadny K.R., Wahl R.L. Standardized uptake values of normal tissues at PET with 2-[fluorine-18]-fluoro-2-deoxy-D-glucose variations with body weight and a method for correction . Radiology. 189:1993;847-850.
17. Pretreatment evaluation of non-small-cell lung cancer. Am J Respir Crit Care Med. 156:1997;320-332.
18. Kubota R., Kubota K., Yamada S., Tada M., Icb T., Tamahasi N. Microautoradiographic study for the differentiation of intratumoral macrophages, granulation tissues and cancer cells by the dynamics of fluorine-18-fluorodeoxyglucose uptake. J Nucl Med. 35:1994;104-112.
19. Scott W.J., Gobar L.S., Terry J.D., Dewan N.A., Sunderland J.J. Mediastinal lymph node staging of non-small cell lung cancer a prospective comparison of computerized tomography and positron emission tomography . J Thorac Cardiovasc Surg. 111:1996;642-648.
20. Kadri M.A., Dussek J.E. Survival and prognosis following resection of primary non small cell bronchogenic carcinoma. Eur J Cardio-thorac Surg. 5:1991;132-136.
21. Larcos G., Maisey M. FDG PET screening for cerebral metastases in patients with suspected malignancy. Nucl Med Commun. 17:1996;197-198.
22. Yokoi K., Miyazawa N., Arai T. Brain metastasis in resected lung cancer value of intensive follow up with computed tomography . Ann Thorac Surg. 61:1996;546-551.
23. Duhaylongsod F.G., Lowe V.J., Patz E.F., Vaughan A.L., Coleman R.E., Wolfe W.G. Lung tumor growth correlates with glucose metabolism measured by fluoride-18-fluorodeoxyglucose positron emission tomography. Ann Thorac Surg. 60:1995;1348-1352.